Highlights and Quick Summary
- Annual ROE for 2022 was -631.78% (a 297.15% increase from previous year)
- Annual ROE for 2022 was -159.08% (a 129.29% increase from previous year)
- Annual ROE for 2021 was -69.38% (a -24.41% decrease from previous year)
- Twelve month ROE ending March 31, 2023 was -326.46% (a 71.75% increase compared to previous quarter)
- Twelve month trailing ROE increased by 105.22% year-over-year
Trailing ROE for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| -326.46% | -190.08% | -121.35% | -159.08% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROE of Benitec Biopharma Limited
Most recent ROEof BNTC including historical data for past 10 years.Interactive Chart of ROE of Benitec Biopharma Limited
Benitec Biopharma Limited ROE for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -631.78% |
| 2021 | – | – | – | – | -69.38% |
| 2020 | – | – | – | – | -80.82% |
| 2019 | – | – | – | – | 15.72% |
| 2018 | – | – | – | – | -63.61% |
| 2017 | – | – | – | – | -26.23% |
| 2016 | – | – | – | – | -130.09% |
| 2015 | – | – | – | – | -37.94% |
| 2014 | – | – | – | – | -41.1% |
| 2013 | – | – | – | – | -22.78% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology